Chestnut Hill, MA, United States of America

Towia Aron Libermann

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Beth Israel Deaconess Medical Center, Inc., Children's Medical Center Corporation, The Board of Regents of the University of Nebraska. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Towia Aron Libermann. Retrieved from https://idiyas.com/inventor/towia-aron-libermann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 62.5

 

 

Average Co-Inventor Count = 3.2

ph-index = 1


Location History:

  • Newton, MA (US) (2005)
  • Chestnut Hill, MA (US) (2014 - 2023)

Company Filing History:


Years Active: 2005-2026

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Towia Aron Libermann: Innovator in Medical Diagnostics and Treatments

Introduction

Towia Aron Libermann is a notable inventor based in Chestnut Hill, MA (US), recognized for his significant contributions to medical diagnostics and treatments. With a total of seven patents to his name, Libermann has focused on addressing critical health issues, particularly in the fields of liver disease and gastrointestinal disorders.

Latest Patents

Libermann's latest patents include innovative methods for diagnosing and treating non-alcoholic steatohepatitis (NASH) and advanced liver fibrosis. His methods involve detecting levels of various biomarkers that differentiate NASH from simple steatosis and NASH with advanced liver fibrosis from NASH without advanced liver fibrosis. Additionally, he has developed treatment methods for NASH by administering biomarkers or agents that modulate these biomarkers. His inventions also encompass compositions in the form of kits and panels of reagents for detecting these biomarkers.

Another significant area of his work involves methods and compositions for treating celiac disease. This invention addresses gastrointestinal disorders linked to an innate immune response triggered by specific alpha amylase inhibitors. The pharmaceutical compositions he has developed include neutralizing antibodies and food products with reduced levels of these proteins. His work also features assays for identifying these proteins in food products and diagnosing related disorders.

Career Highlights

Throughout his career, Libermann has worked with esteemed institutions such as Beth Israel Deaconess Medical Center and Children's Medical Center Corporation. His experience in these organizations has contributed to his expertise in medical research and innovation.

Collaborations

Some of his notable coworkers include Simon T. Dillon and Detlef Schuppan, who have collaborated with him on various projects related to his patents and research.

Conclusion

Towia Aron Libermann's contributions to medical diagnostics and treatments have made a significant impact in the healthcare field. His innovative patents and collaborations reflect his dedication to improving patient outcomes through advanced medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…